Peter N Black

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. ncbi request reprint Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey
    Peter N Black
    Department of Medicine, University of Auckland, Private Bag 92019 Auckland, New Zealand
    Chest 128:3792-8. 2005
  2. ncbi request reprint Antibiotics for the treatment of asthma
    Peter N Black
    Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
    Curr Opin Pharmacol 7:266-71. 2007
  3. pmc How often do physicians review medication charts on ward rounds?
    Khang Li Looi
    Dept of Pharmacology and Clinical Pharmacology, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    BMC Clin Pharmacol 8:9. 2008
  4. ncbi request reprint Role of antibiotics in the management of chronic obstructive pulmonary disease
    Peter N Black
    Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Expert Rev Respir Med 2:235-43. 2008
  5. ncbi request reprint Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand
    P N Black
    Department of Medicine, University of Auckland, New Zealand
    Eur J Clin Pharmacol 56:431-5. 2000
  6. doi request reprint Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease
    P N Black
    Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
    Postgrad Med J 85:141-7. 2009
  7. doi request reprint Changes in elastic fibres in the small airways and alveoli in COPD
    P N Black
    Dept of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Eur Respir J 31:998-1004. 2008
  8. ncbi request reprint Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae
    P N Black
    Auckland Hospital, Auckland, New Zealand
    Am J Respir Crit Care Med 164:536-41. 2001
  9. doi request reprint Dietary intakes of European, Māori, Pacific and Asian adults living in Auckland: the Diabetes, Heart and Health Study
    Patricia A Metcalf
    Division of Epidemiology and Biostatistics and Department of Statistics, University of Auckland, Auckland, New Zealand
    Aust N Z J Public Health 32:454-60. 2008
  10. doi request reprint Prevalence and determinants of cytomegalovirus infection in pre-school children
    TIMOTHY P O'BRIEN
    Departments of Paediatrics, University of Auckland, Private Bag 92019, Auckland, New Zealand
    J Paediatr Child Health 45:291-6. 2009

Detail Information

Publications29

  1. ncbi request reprint Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey
    Peter N Black
    Department of Medicine, University of Auckland, Private Bag 92019 Auckland, New Zealand
    Chest 128:3792-8. 2005
    ..Low concentrations of vitamin D have been associated with a number of diseases, including osteoporosis, hypertension, and type I diabetes. It is possible that serum concentrations of vitamin D might also influence pulmonary function...
  2. ncbi request reprint Antibiotics for the treatment of asthma
    Peter N Black
    Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
    Curr Opin Pharmacol 7:266-71. 2007
    ..It is not clear whether any effect that these antibiotics has is a result of antimicrobial actions against organisms such as C. pneumoniae or whether it is due to their anti-inflammatory action...
  3. pmc How often do physicians review medication charts on ward rounds?
    Khang Li Looi
    Dept of Pharmacology and Clinical Pharmacology, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    BMC Clin Pharmacol 8:9. 2008
    ..The aim of this study was to determine the frequency with which specialist physicians reviewed medication charts during ward rounds...
  4. ncbi request reprint Role of antibiotics in the management of chronic obstructive pulmonary disease
    Peter N Black
    Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Expert Rev Respir Med 2:235-43. 2008
    ..Until the full results of these studies are published, it will not be clear if they should be used...
  5. ncbi request reprint Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand
    P N Black
    Department of Medicine, University of Auckland, New Zealand
    Eur J Clin Pharmacol 56:431-5. 2000
    ..To determine whether the average doses of inhaled beclomethasone, fluticasone and budesonide prescribed in primary care reflect the relative potencies of these medicines...
  6. doi request reprint Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease
    P N Black
    Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
    Postgrad Med J 85:141-7. 2009
    ..Other interventions including oral bacterial extracts and self-management programmes warrant further study...
  7. doi request reprint Changes in elastic fibres in the small airways and alveoli in COPD
    P N Black
    Dept of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Eur Respir J 31:998-1004. 2008
    ..Loss of elastic fibres in small airways may contribute to the development of airflow obstruction in chronic obstructive pulmonary disease...
  8. ncbi request reprint Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae
    P N Black
    Auckland Hospital, Auckland, New Zealand
    Am J Respir Crit Care Med 164:536-41. 2001
    ..Further studies are necessary to determine whether the lack of sustained benefit is due to failure to eradicate C. pneumoniae...
  9. doi request reprint Dietary intakes of European, Māori, Pacific and Asian adults living in Auckland: the Diabetes, Heart and Health Study
    Patricia A Metcalf
    Division of Epidemiology and Biostatistics and Department of Statistics, University of Auckland, Auckland, New Zealand
    Aust N Z J Public Health 32:454-60. 2008
    ..To compare dietary intakes of European, Māori, Pacific, and Asian men and women living in Auckland...
  10. doi request reprint Prevalence and determinants of cytomegalovirus infection in pre-school children
    TIMOTHY P O'BRIEN
    Departments of Paediatrics, University of Auckland, Private Bag 92019, Auckland, New Zealand
    J Paediatr Child Health 45:291-6. 2009
    ..The aim of this study is to measure the seroprevalence of cytomegalovirus (CMV) infection in 3.5-year-old children, and identify the determinants of seropositivity...
  11. pmc Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study
    Angharad R Morgan
    Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
    BMC Med Genet 11:125. 2010
    ..However, in a large proportion of SGA, no underlying cause is evident, and these individuals may have a larger genetic contribution...
  12. pmc Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease
    Mervyn J Merrilees
    Department of Anatomy with Radiology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
    Respir Res 9:41. 2008
    ..This study aimed to determine if alveoli of patients with mild to moderate COPD contained increased amounts of versican and a corresponding decrease in EBP, and if these changes were correlated with decreases in elastin and FEV1...
  13. doi request reprint The cyclooxygenase-2-765C promoter polymorphism protects against the development of chronic obstructive pulmonary disease
    Lian Wu
    Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Respir Med 105:506-10. 2011
    ..Susceptibility to Chronic Obstructive Pulmonary Disease (COPD) has a genetic component. We undertook a study to determine if a genetic variant of the gene encoding the cyclooxygenase-2 gene influences the likelihood of developing COPD...
  14. ncbi request reprint Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey
    Patricia A Metcalf
    Division of Epidemiology and Biostatistics, School of Population Health, Tamaki Campus, University of Auckland, Private Bag 92019, Auckland, New Zealand
    N Z Med J 121:45-56. 2008
    ..To compare different markers of socioeconomic status (SES) with cardiovascular disease (CVD) and diabetes risk factors...
  15. ncbi request reprint Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole
    Mark J Bolland
    Department of Endocrinology, Auckland Hospital, Auckland, New Zealand
    Ann Pharmacother 38:46-9. 2004
    ..To report a case of an interaction between inhaled corticosteroids and itraconazole causing iatrogenic Cushing's syndrome and provide a review of the relevant literature...
  16. doi request reprint Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
    Phillippa Poole
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Cochrane Database Syst Rev 8:CD001287. 2012
    ..There is a marked difference among countries in terms of prescribing of mucolytics depending on whether or not they are perceived to be effective...
  17. ncbi request reprint Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
    Phillippa Poole
    University of Auckland, Private Bag 92019, Auckland, New Zealand
    Cochrane Database Syst Rev 2:CD001287. 2010
    ..Mucolytics should be considered for use, through the winter months at least, in patients with moderate or severe COPD in whom inhaled corticosteroids (ICS) are not prescribed...
  18. ncbi request reprint Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis
    Claire Arandjus
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Respir Med 100:1671-81. 2006
    ..Further trials are needed before the use of oral vaccines could be considered as part of the routine clinical management of patients with COPD or chronic bronchitis...
  19. ncbi request reprint Serum lipid levels for a multicultural population in Auckland, New Zealand: results from the Diabetes Heart and Health Survey (DHAH) 2002-2003
    Dudley Gentles
    Department of Epidemiology and Biostatistics, School of Population Health, Tamaki Campus, University of Auckland, Auckland
    N Z Med J 120:U2800. 2007
    ..To describe mean serum lipid concentrations for Maori, Pacific people (mostly of Samoan, Tongan, Niuean, or Cook Islands origin), and Others (mostly New Zealand-born Europeans), and to identify risk factors for an adverse lipid profile...
  20. doi request reprint Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung
    Jing Zhang
    Department of Pulmonary Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
    J Cell Mol Med 16:1522-32. 2012
    ..Versican inhibits assembly of tropoelastin into insoluble elastin and we conclude that the pro-inflammatory phenotype of COPD fibroblasts is not compatible with repair of elastic fibres...
  21. pmc Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative Study
    Nikki J Blair
    Department of Paediatrics, University of Auckland, Auckland, New Zealand
    Arch Dis Child 92:866-71. 2007
    ..To identify risk factors associated with obesity in primary school children, with a particular focus on those which can be modified. To identify critical periods and growth patterns in the development of childhood obesity...
  22. doi request reprint Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD
    Lian Wu
    Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    Respir Med 105:329-36. 2011
    ..AGEs are proinflammatory and can modify the extracellular matrix. RAGE (Receptor for Advanced Glycation End Products) mediates some of the effects of AGEs...
  23. pmc Effect of education on the recording of medicines on admission to hospital
    Amy Hai Yan Chan
    Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand
    J Gen Intern Med 25:537-42. 2010
    ..The inaccurate recording of medicines on admission to hospital is an important cause of medication error. Medication reconciliation has been used to identify and correct these errors...
  24. pmc Lung cancer susceptibility model based on age, family history and genetic variants
    Robert P Young
    Department of Medicine, Auckland Hospital, Auckland, New Zealand
    PLoS ONE 4:e5302. 2009
    ..In a case control association study of healthy smokers and lung cancer cases, we identified genetic markers associated with either susceptibility or protection to lung cancer...
  25. ncbi request reprint Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents
    Phillippa J Poole
    University of Auckland, Auckland, New Zealand
    Am J Respir Med 2:367-70. 2003
    ..Those with more frequent and severe exacerbations appear to have the most to gain...
  26. ncbi request reprint Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
    Jimmy Chong
    University of Auckland, Auckland, New Zealand
    Cochrane Database Syst Rev 5:CD002309. 2011
    ..Roflumilast and cilomilast are oral phosphodiesterase 4 (PDE(4)) inhibitors proposed to reduce the airway inflammation and bronchoconstriction seen in COPD...
  27. ncbi request reprint The effect of telithromycin in acute exacerbations of asthma
    Sebastian L Johnston
    Department of Respiratory Medicine, National Heart and Lung Institute and Wright Fleming Institute of Infection and Immunity, National Heart and Lung Institute, Imperial College London, United Kingdom
    N Engl J Med 354:1589-600. 2006
    ..We conducted a double-blind, randomized, placebo-controlled study to evaluate the efficacy of telithromycin in patients with acute exacerbations of asthma...
  28. ncbi request reprint Reducing asthma treatment
    Peter N Black
    N Engl J Med 357:504; author reply 505-6. 2007
  29. pmc Short sleep duration in middle childhood: risk factors and consequences
    Gillian M Nixon
    Ritchie Centre obr Baby Health Research, Monash Institute of Medical Research, Monash University, Melbourne, Australia
    Sleep 31:71-8. 2008
    ..To measure sleep duration in 7-year-old children; identify the determinants of sleep duration; and assess the association between short sleep duration and obesity, cognitive functioning, and behaviour...